BRIEF published on 05/20/2024 at 10:56, 10 months 17 days ago Novacyt announces the publication of its financial results and convenes its Annual General Meeting Financial Results Investors Webinar General Assembly Novacyt
BRIEF published on 05/20/2024 at 10:54, 10 months 17 days ago Novacyt Announces Financial Results and Annual General Meeting Financial Results AGM Molecular Diagnostics Investor Webinar Novacyt
BRIEF published on 05/20/2024 at 10:54, 10 months 17 days ago Novacyt annonce ses résultats financiers et son assemblée générale annuelle Résultats Financiers AGA Diagnostic Moléculaire Webinaire Pour Les Investisseurs Novacyt
PRESS RELEASE published on 05/20/2024 at 10:51, 10 months 17 days ago Avis sur les résultats et de convocation à l’Assemblée Générale Annuelle Novacyt S.A. annonce ses résultats financiers et la convocation à l'Assemblée Générale Annuelle. Un webinaire pour les investisseurs est prévu avec présentation et session de questions-réponses Résultats Financiers Assemblée Générale Annuelle Diagnostic Moléculaire Novacyt S.A. Webinaire Investisseurs
PRESS RELEASE published on 05/20/2024 at 10:49, 10 months 17 days ago Notice of Results and Annual General Meeting Novacyt S.A. will report its audited financial results for the year ended 31 December 2023 on 30 May 2024 and hold its Annual General Meeting on 26 June 2024. An investor webinar is scheduled for 30 May 2024 Financial Results Annual General Meeting Molecular Diagnostics Investor Webinar Novacyt S.A.
Published on 04/07/2025 at 00:05, 7 hours 20 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 22 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 25 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 13 hours 4 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 16 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 24 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 24 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 13 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
